HER2 Positive Breast Cancers Active Not Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

Also known as: HER2 Positive Breast Cancer

IndicationStatusPhase
DBCOND0066412 (HER2 Positive Breast Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01904903Cardiac Safety Study in Patients With HER2 + Breast CancerTreatment